Prospective Longitudinal Cohort Study of Vasculitis Patients
NCT04413331 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 670
Last updated 2025-09-12
Summary
VASCO is a prospective observational cohort study which aim to describe the presentation, comorbidities, management, outcomes and damage of vasculitis patients, from the analysis of the clinical, biological and immunological data.
Conditions
- Vasculitis
Interventions
- OTHER
-
Data collection
Medical data collection at M0, M3, M6, M9 and M12 then every 6 months until M60 and at each vascularitis relapse
- OTHER
-
Biological samples and data collection
Biological samples at M0, M6, M12, M24 and at each relapse until M60
Sponsors & Collaborators
-
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-02
- Primary Completion
- 2027-07-31
- Completion
- 2032-07-31
Countries
- France
Study Locations
More Related Trials
-
Multicenter Cohort Study of AAV in Hunan of China
NCT05315141 ·Status: RECRUITING
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)
NCT05416723 ·Status: UNKNOWN
-
Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
NCT04564001 ·Status: UNKNOWN ·Phase: PHASE2
-
Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis
NCT05168475 ·Status: TERMINATED ·Phase: PHASE2
-
The Registry Study of Takayasu Arteritis in East China
NCT03893136 ·Status: RECRUITING
-
Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
NCT01731561 ·Status: COMPLETED ·Phase: PHASE3
-
One-Time DNA Study for Vasculitis
NCT01241305 ·Status: RECRUITING
-
Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
NCT04008316 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Refractory and/or Relapsing TAkayasu aRTeritis
NCT03543527 ·Status: UNKNOWN
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
Contrast-Enhanced US of Spleen, Liver and Kidney
NCT00190281 ·Status: UNKNOWN
-
Alemtuzumab for ANCA Associated Refractory Vasculitis
NCT01405807 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3
-
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942 ·Status: COMPLETED
-
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290 ·Status: COMPLETED
-
Rapid Diagnostic Test for Septic Arthritis
NCT04460144 ·Status: COMPLETED
-
Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
NCT01934504 ·Status: TERMINATED
-
Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease
NCT01440075 ·Status: COMPLETED ·Phase: NA
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
NCT06742671 ·Status: RECRUITING
-
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
NCT03371095 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Vasculitis Initiative
NCT02006134 ·Status: RECRUITING
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN